Okay, let's tackle this question about MRSA drug resistance. First, I need to recall the core concept. MRSA, or methicillin-resistant Staphylococcus aureus, is known for developing resistance through various mechanisms.

The question is asking for a true statement about how MRSA becomes resistant. The correct answer is probably related to the mecA gene and PBP2a. I remember that mecA codes for an altered penicillin-binding protein (PBP2a) which has low affinity for beta-lactam antibiotics, making them ineffective. That's a key mechanism.

Now, looking at the options (even though they're not listed here), common distractors might include other resistance mechanisms like efflux pumps, enzymatic degradation (like beta-lactamases), or changes in cell wall structure. But MRSA's main resistance is definitely due to the mecA gene and PBP2a. So the correct answer should highlight that.

For the wrong options, if any mention beta-lactamases, that's incorrect because MRSA's resistance isn't primarily from those enzymes. Efflux pumps might be involved in other bacteria but not the mainstay in MRSA. Also, options about ribosomal modifications would be for other antibiotics like macrolides.

Clinical pearl: Remember that MRSA's resistance is due to the mecA gene encoding PBP2a, not beta-lactamases. This differentiates it from other resistant strains. So, the correct answer is the one that states the mecA gene leads to altered PBPs with low affinity for beta-lactams.

**Core Concept**
Methicillin-resistant *Staphylococcus aureus* (MRSA) develops resistance via the **mecA gene**, which encodes **PBP2a (penicillin-binding protein 2a)**. This protein has low affinity for beta-lactam antibiotics, bypassing their inhibitory effect on cell wall synthesis.

**Why the Correct Answer is Right**
MRSA’s resistance mechanism is **not mediated by beta-lactamases** (enzymatic degradation) but by **intrinsic penicillin-binding protein alteration**. The mecA gene is carried on a mobile genetic element called **SCCmec (staphylococcal cassette chromosome mec)**, which integrates into the bacterial genome. PBP2a competes with other PBPs during cell wall cross-linking, rendering beta-lactams ineffective. This is the **primary mechanism** of methicillin resistance in MRSA.

**Why Each Wrong Option is Incorrect**
**Option A:** *Beta-lactamase production is incorrect*—MRSA is resistant to beta-lactamase inhibitors (e.g., clavulanic acid), but its resistance stems from PBP2a, not enzymatic degradation.
**Option B:** *Altered ribosomal binding sites are incorrect*—This mechanism is typical of **macrolide** resistance (e.g., erythromycin), not MRSA.
**Option D:** *Efflux pump overexpression is incorrect*—While efflux pumps contribute to multidrug resistance in some pathogens (e.g., *Pseudomonas*), they are **not primary in MRSA’s beta-lactam resistance**.

**Clinical Pearl / High-Yield Fact**
MRSA resistance is **mecA-dependent

✓ Correct Answer: B. Occurs due to change in penicillin blinding proteins